News Desk, News Nation 360 : Ahead of its IPO, Suraksha Diagnostic Limited, situated in Kolkata, has raised Rs. 253 crores from 16 anchor investors. The anchor book included shares from a number of well-known companies, including Carnelian Bharat Amritkaal Fund, Societe Generale, Integrated Core Strategies (Asia), Troo Capital, Tusk Investments, and mutual funds, including Aditya Birla Sunlife MF, Bandhan MF, JM Financial, Kotak MF, Mirae Asset MF, Nippon MF, and Quant MF. The price range for Suraksha Diagnostic's initial public offering (IPO) is ₹420 per equity share to ₹441 per equity share, and it opens on Friday, November 29, 2024, and ends on Tuesday, December 3, 2024. A one-stop shop for integrated diagnostics, Suraksha Diagnostics provides radiology and pathology testing as well as medical consultation services. Suraksha is a premier diagnostic services provider offering more than 2,300 tests across specialities, such as routine and specialized pathology tests, and a wide array of radiology services that range from basic to advanced imaging techniques. In Fiscal 2024, Suraksha conducted approximately 5.98 million tests on 1.14 million patients. The Indian diagnostics services market is growing at an impressive rate, with a projected market size of ₹127,500 crores for Fiscal 2028. A promising growth opportunity exists in the eastern and north-eastern regions of India, with an estimated market size of ₹17,000 crores in Fiscal 2024 and projected to grow between 10.5% to 12.5% annually, reaching nearly ₹26,000 crores by Fiscal 2028.
Pic - Courtesy
